To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.
General Information
DRAVP ID DRAVPe01869
Peptide Name FP2
Sequence WLVFFVIAYFAR
Sequence Length 12
UniProt ID No entry found
Source Synthetic construct
Activity Information
Target Organism Influenza virus
Assay Plaque reduction assay
Activity
Hemolytic Activity No hemolysis information or data found in the reference(s) presented in this entry
Cytotoxicity
Binding Target HA
Mechanism the mechanism whereby FluPep mediates its antiviral effects is likely to involve inhibiting the binding of HA to sialic acid receptors or through interference with the fusion process by blocking protease cleavage.
Structure Information
PDB ID None
Predicted Structure Download No predicted structure available
Linear/Cyclic Linear
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Stereochemistry L
Physicochemical Information
Formula C81H110N16O14
Absent amino acids CDEGHKMNPQST
Common amino acids F
Mass 1531.86
Pl 8.75
Basic residues 1
Acidic residues 0
Hydrophobic residues 10
Net charge 1
Boman Index 1775
Hydrophobicity 183.33
Aliphatic Index 130
Half Life
Extinction Coefficient cystines 6990
Absorbance 280nm 635.45
Polar residues 1
Literature Information
Literature 1
Title A novel family of peptides with potent activity against influenza A viruses.
Pubmed ID 22258859
Reference J Gen Virol. 2012 May;93(Pt 5):980-986.
Author Nicol MQ, Ligertwood Y, Bacon MN, Dutia BM, Nash AA.
To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.